An Unbiased View of pharmaceutical documentation
This direction just isn't intended to determine registration and/or filing needs or modify pharmacopoeial requirements. This assistance isn't going to impact the flexibility on the liable regulatory company to establish unique registration/filing prerequisites about APIs within the context of selling/manufacturing authorizations or drug application